World's Best Scientists 2026 revealed!
Headache
H-index 37

Headache

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 499 97 240 35

Additional Metrics

Number of Best Scientists*: 195
Documents by Best Scientists*: 338
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 146
SCIMAGO SJR: 1.426
Impact Factor: 4

Overview

Top Research Topics at Headache?

The primary areas of discussion in Headache are Migraine, Anesthesia, Headaches, Internal medicine and Neurological disorder. It facilitates discussions on Migraine that incorporate concepts from other fields like Physical therapy and Pediatrics. Physical therapy research discussed connects with the study of Tension headache.

Topics in Anesthesia explored in Headache were investigated in conjunction with research in Placebo, Adverse effect, Surgery and Sumatriptan. The Placebo study featured in it draws parallels with the field of Randomized controlled trial. While Internal medicine is the focus of Headache, it also provided insights into the studies of Endocrinology and Cardiology.

The journal focused on Neurological disorder research conducted under the discipline of Central nervous system disease. Headache dives deep in exploring the relationship between the study of Central nervous system disease and Vascular disease. Migraine with aura is a major topic of Aura research presented in the journal.

  • Migraine (44.99%)
  • Anesthesia (27.26%)
  • Headaches (15.23%)

What are the most cited papers published in the journal?

  • Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II (1782 citations)
  • The International Classification of Headache Disorders (1492 citations)
  • Epidemiology of Chronic Daily Headache in the General Population (622 citations)

Research areas of the most cited articles at Headache:

The most cited papers are organized to reinforce research efforts on Migraine, Anesthesia, Neurological disorder, Headaches and Physical therapy. The study on Migraine presented in the most cited papers is investigated in conjunction with research in Pediatrics. In addition to Anesthesia research, the journal publications aim to explore topics under Adverse effect, Placebo and Randomized controlled trial, Surgery.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Surgery
  • Disease

The previous edition focused in particular on these issues:

The journal aims to foster the development of research in Higher education, Educational systems, Migraine, Coronavirus disease 2019 (COVID-19) and Internal medicine. The work on Higher education tackled in Headache brings together disciplines like Mathematics education, Employability and Medical education. The Educational systems works featured in the journal incorporate elements from Engineering ethics and Public relations.

It centers on topics in Migraine, with a focus on Chronic Migraine. The featured Coronavirus disease 2019 (COVID-19) studies mainly concentrate on 2019-20 coronavirus outbreak but also cover areas of interest in Family medicine. Headache investigates Internal medicine research which frequently intersects with Placebo.

The most cited articles from the last journal are:

  • Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation. (9 citations)
  • Remote electrical neuromodulation for acute treatment of migraine in adolescents. (8 citations)
  • Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Headache (based on the number of publications) are:

  • Richard B. Lipton (221 papers) published 16 papers at the last edition, 4 more than at the previous edition,
  • Randolph W. Evans (174 papers) absent at the last edition,
  • Stephen D. Silberstein (153 papers) published 4 papers at the last edition, 1 less than at the previous edition,
  • David W. Dodick (114 papers) published 12 papers at the last edition, 2 more than at the previous edition,
  • Stewart J. Tepper (102 papers) published 6 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Headache (based on the number of publications) are:

  • Albert Einstein College of Medicine (269 papers) published 21 papers at the last edition, 4 more than at the previous edition,
  • Mayo Clinic (253 papers) published 29 papers at the last edition, 2 less than at the previous edition,
  • Cleveland Clinic (129 papers) published 1 paper at the last edition,
  • Harvard University (120 papers) published 8 papers at the last edition, 11 less than at the previous edition,
  • Brigham and Women's Hospital (111 papers) published 11 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 22.64% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.95% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.57% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.80% of all publications and 61.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Further Resources for Aspiring Researchers in New Hampshire

It’s clear that a multitude of research areas are being explored in the publication, Headache. If you're an aspirant researcher in New Hampshire, specifically interested in medicine, these areas might be of particular interest to you. You might even want to consider a career in a relevant medical profession, such as nursing, which could provide a practical foundation for your research. For individuals interested in the medical field, it might be useful to understand the pathways to becoming a registered nurse in New Hampshire. Here's a relevant article detailing the requirements and processes on how to become a registered nurse in New Hampshire online. This resource can provide a comprehensive understanding of how one can initiate their career in nursing in New Hampshire, ultimately equipping them with the skills to contribute valuable research in relevant areas such as Anesthesia, Pediatrics, and Internal Medicine. Whether you're planning to conduct research in Neurological disorder or otherwise, having a practical understanding of your subject area is undeniably beneficial. Remember, thriving in the realm of research not only requires in-depth knowledge in your specific field but also a keen understanding of related disciplines and continuous learning. So, start with exploring different career pathways, learn from established professionals and never stop discovering.

Top Publications

  • COVID-19 is a Real Headache!

    Hayrunnisa Bolay;Ahmet Gül;Betül Baykan

    (2020)
    266 Citations
  • Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.

    Rami Burstein;Rami Burstein;Andrew M. Blumenfeld;Stephen D. Silberstein;Aubrey Manack Adams;Aubrey Manack Adams

    (2020)
    138 Citations
  • Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study.

    Piero Barbanti;Cinzia Aurilia;Gabriella Egeo;Luisa Fofi

    (2021)
    118 Citations
  • Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

    (2022)
    111 Citations
  • Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial

    (2022)
    98 Citations
  • Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?

    Lanfranco Pellesi;Thien P. Do;Håkan Ashina;Messoud Ashina

    (2020)
    80 Citations
  • Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study

    Sagar Munjal;Preeti Singh;Michael L. Reed;Kristina Fanning

    (2020)
    79 Citations
  • Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.

    Gary Berman;Robert Croop;David Kudrow;Philip Halverson

    (2020)
    78 Citations
  • Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2

    Hans Christoph Diener;Michael J. Marmura;Stewart J. Tepper;Robert Cowan

    (2021)
    76 Citations
  • Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial

    Jessica Ailani;Richard B. Lipton;Susan Hutchinson;Kerry Knievel

    (2020)
    76 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can provide valuable alternatives and complementary skills. Programs like nutrition degree programs offer a foundation in dietary sciences, which is essential for holistic patient care and preventive medicine.

Healthcare professionals seeking leadership roles may consider pursuing a cheapest online mba in healthcare management. This degree equips students with the business acumen necessary to navigate healthcare systems efficiently and advance into management positions.

Nurses who want to further their clinical expertise without traditional full-time study can explore the best online bsn programs for non nurses. These accelerated pathways are designed for individuals transitioning into nursing, helping address workforce shortages.

For those drawn to mental health, becoming a psychiatric nurse practitioner is a promising career. Understanding the psychiatric nurse practitioner salary by state can guide candidates on potential earnings and regional opportunities within this in-demand specialty.

Best Scientists Contributing to This Journal